Hyaluronan activated-metabolism phenotype (HAMP) in pancreatic ductal adenocarcinoma.

Kudo, Yuzan; Kohi, Shiro; Hirata, Keiji; Goggins, Michael; Sato, Norihiro

Kudo, Yuzan; Kohi, Shiro; Hirata, Keiji; Goggins, Michael; Sato, Norihiro.

Afiliación

Kudo Y; Department of Surgery 1, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan.
Kohi S; Department of Surgery 1, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan.
Hirata K; Department of Pathology, Sol Goldman Pancreatic Cancer Research Center, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Goggins M; Department of Surgery 1, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan.
Sato N; Department of Pathology, Sol Goldman Pancreatic Cancer Research Center, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

Oncotarget ; 10(54): 5592-5604, 2019 Sep 24.

Article en En | MEDLINE | ID: mdl-31608136

Palabras clave

degradation; hyaluronan; pancreatic cancer; prognosis; synthesis

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Oncotarget Año: 2019 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google